國盾量子(688027.SH):已推出極低温極低噪聲平台、超導量子計算操控系統等產品
格隆匯1月23日丨國盾量子(688027.SH)在投資者互動平台表示,目前的量子計算機並不是通用的計算機設備,必須進一步攻關量子糾錯等難題,才能走向通用。現階段量子計算處於工程實驗驗證和原型樣機研發的攻堅期,隨着“量子計算優越性”的凸顯,量子計算相關科學研究、應用研究和教學、科普等市場需求不斷增長,與之相關的儀器設備市場和產業也因此加速發展。當前,國盾量子圍繞量子計算業務,已推出極低温極低噪聲平台、超導量子計算操控系統等產品,同時,推出了新一代量子計算雲平台,旨在提供以量子計算機為核心的雲服務,通過對全社會開放,共同探索未來量子計算在相關領域的應用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.